"Space-Made Cancer Drugs and Moonshot Progress: First Lady Unveils Expansion Plan"

BioOrbit, founded by Katie King, plans to revolutionize cancer drug production by crystallizing proteins in microgravity in space, allowing for higher drug concentrations and easier administration. The company aims to commercialize this process after securing funding from the European Space Agency and plans to test it on the International Space Station. While there are challenges such as cost and regulation, King sees the potential for microgravity to significantly benefit drug development and hopes to establish a permanent facility in space for research and manufacturing.